JP Morgan Chase’s NEOPHOTONICS CORP NPTN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | – | Sell |
-744,968
| Closed | -$11.7M | – | 7165 |
|
|
2022
Q2 | $11.7M | Buy |
744,968
+173,027
| +30% | +$2.64M | ﹤0.01% | 2022 |
|
|
2022
Q1 | $8.7M | Buy |
571,941
+391,563
| +217% | +$5.96M | ﹤0.01% | 2512 |
|
|
2021
Q4 | $2.77M | Buy |
180,378
+129,875
| +257% | +$1.71M | ﹤0.01% | 3572 |
|
|
2021
Q3 | $440K | Sell |
50,503
-49,492
| -49% | -$451K | ﹤0.01% | 4804 |
|
|
2021
Q2 | $1.02M | Sell |
99,995
-865,552
| -90% | -$9.14M | ﹤0.01% | 4272 |
|
|
2021
Q1 | $11.5M | Sell |
965,547
-194,979
| -17% | -$2.21M | ﹤0.01% | 2235 |
|
|
2020
Q4 | $10.6M | Buy |
1,160,526
+17,006
| +1% | +$132K | ﹤0.01% | 2173 |
|
|
2020
Q3 | $7.02M | Buy |
1,143,520
+907,288
| +384% | +$6.92M | ﹤0.01% | 2304 |
|
|
2020
Q2 | $2.1M | Sell |
236,232
-1,256,078
| -84% | -$10.8M | ﹤0.01% | 3075 |
|
|
2020
Q1 | $10.8M | Sell |
1,492,310
-830,705
| -36% | -$6.16M | ﹤0.01% | 1681 |
|
|
2019
Q4 | $20.5M | Buy |
2,323,015
+1,614,282
| +228% | +$12.1M | ﹤0.01% | 1575 |
|
|
2019
Q3 | $4.32M | Buy |
708,733
+14,948
| +2% | +$84K | ﹤0.01% | 2822 |
|
|
2019
Q2 | $2.94M | Sell |
693,785
-268,405
| -28% | -$1.42M | ﹤0.01% | 3104 |
|
|
2019
Q1 | $6.05M | Buy |
962,190
+554,494
| +136% | +$3.88M | ﹤0.01% | 2443 |
|
|
2018
Q4 | $2.64M | Buy |
407,696
+255,014
| +167% | +$1.95M | ﹤0.01% | 3088 |
|
|
2018
Q3 | $1.27M | Buy |
152,682
+141,581
| +1,275% | +$1.08M | ﹤0.01% | 3767 |
|
|
2018
Q2 | $69K | Sell |
11,101
-46,594
| -81% | -$296K | ﹤0.01% | 4965 |
|
|
2018
Q1 | $395K | Buy |
57,695
+47,836
| +485% | +$304K | ﹤0.01% | 4113 |
|
|
2017
Q4 | $65K | Buy |
+9,859
| New | +$60.2K | ﹤0.01% | 4812 |
|
|
2017
Q3 | – | Sell |
-1,685
| Closed | -$13K | – | 5272 |
|
|
2017
Q2 | $13K | Sell |
1,685
-46,321
| -96% | -$391K | ﹤0.01% | 4618 |
|
|
2017
Q1 | $433K | Sell |
48,006
-83,174
| -63% | -$867K | ﹤0.01% | 3777 |
|
|
2016
Q4 | $1.42M | Sell |
131,180
-1,320
| -1% | -$17.6K | ﹤0.01% | 3272 |
|
|
2016
Q3 | $2.17M | Buy |
132,500
+1,400
| +1% | +$19.7K | ﹤0.01% | 2755 |
|
|
2016
Q2 | $1.25M | Buy |
131,100
+2,170
| +2% | +$23.6K | ﹤0.01% | 3066 |
|
|
2016
Q1 | $1.81M | Buy |
+128,930
| New | +$1.33M | ﹤0.01% | 2751 |
|
|
2013
Q4 | – | Sell |
-11,771
| Closed | -$87K | – | 4291 |
|
|
2013
Q3 | $87K | Buy |
+11,771
| New | +$91.6K | ﹤0.01% | 4204 |
|
Other funds holding NPTN
JP Morgan Chase's NPTN Position: Q3 2022 in Review
JP Morgan Chase sold out of NEOPHOTONICS CORP (NPTN) in Q3 2022, closing a stake of 744,968 shares — an estimated $11.7M sold.
JP Morgan Chase first reported a position in NPTN in Q3 2013 and held it in 26 quarters. The position peaked at $20.5M in Q4 2019. 2 funds tracked by Wall St. Rank hold NPTN as of Q3 2022.
- JP Morgan Chase reported no remaining NEOPHOTONICS CORP position as of Q3 2022 after selling out during the quarter.
- JP Morgan Chase sold 744,968 NEOPHOTONICS CORP shares in Q3 2022, an estimated $11.7M.
- JP Morgan Chase first reported a position in NEOPHOTONICS CORP in Q3 2013 and held it in 26 quarters.
- JP Morgan Chase's NEOPHOTONICS CORP position peaked at $20.5M in Q4 2019.
- 2 funds tracked by Wall St. Rank held NEOPHOTONICS CORP as of Q3 2022.
Based on JP Morgan Chase's 13F filing for Q3 2022, filed 14 Nov 2022.